|
23 Jan 2007 |
Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
|
|
23 Jan 2007 |
Sirion Therapeutics Initiates Enrollment of Phase III Clinical Trials for the Treatment of Inflammation Following Ocular Surgery
|
|
23 Jan 2007 |
Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor
|
|
23 Jan 2007 |
Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
|
|
23 Jan 2007 |
MediciNova Initiates Phase II Clinical Trial for MN-305, a Novel Treatment for Insomnia
|
|
20 Jan 2007 |
S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone
|
|
20 Jan 2007 |
Pharmos Corporation Announces Clinical Data From Phase 2a Trial Of Cannabinor For Capsaicin-induced Pain; Drug Ineffective In Trial
|
|
20 Jan 2007 |
Penwest Begins Next Study in Development of Nalbuphine ER
|
|
20 Jan 2007 |
Bionovo Launches Pharmacokinetics Trial of Its Lead Menopause Drug Candidate, MF101
|
|
20 Jan 2007 |
Elbion AG Acquires Late-Stage Product Candidate From DrugAbuse Sciences, Inc. For Treatment Of Alcohol Dependence
|
|
19 Jan 2007 |
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
|
|
19 Jan 2007 |
Anesiva Announces Clinical Data From Phase 1 Trial of 1207
|
|
19 Jan 2007 |
Pfizer's Sutent is Granted Full Marketing Authorization for First-Line Use in Advanced Kidney Cancer in the European Union
|
|
18 Jan 2007 |
Genaera Corporation Announces Presentation Of Data On Trodusquemine Mechanism Of Action In Obesity
|
|
18 Jan 2007 |
Exforge(R) approved in Europe as powerful new blood pressure therapy combining two leading medications in a single pill
|
|
18 Jan 2007 |
Marketing Authorisation Granted for Tandemact (TM) (pioglitazone/glimepiride) for Type 2 Diabetes in Europe
|
|
18 Jan 2007 |
Barrier Therapeutics Announces Positive Phase 2a Data for Oral Hivenyl(TM) in the Treatment of Itch in Atopic Dermatitis
|
|
18 Jan 2007 |
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate From Bayer Schering Pharma
|
|
18 Jan 2007 |
Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA
|
|
18 Jan 2007 |
Neoprobe Receives Clearance For Additional Lymphoseek Trials
|
|
18 Jan 2007 |
Metabolex Shows MBX-102/JNJ-39659100 Reduces Inflammation in Preclinical Models of Diabetes
|
|
18 Jan 2007 |
Elixir Pharmaceuticals Presents Ghrelin Antagonist Program at European Conference on Aging
|
|
17 Jan 2007 |
Merck Serono Announces Positive Results From Phase III Diet Study Of Phenoptin For Phenylketonuria
|
|
17 Jan 2007 |
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
|
|
17 Jan 2007 |
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
|
